Skip to main content

Table 1 The baseline demographics and clinical variables in rheumatic mitral valve repair and replacement

From: Short and mid-term effects of modified release technique in rheumatic mitral valve repair

Clinical Variables

MVP(n = 128)

MVR(n = 128)

P-value

Age(y)

52.7 ± 10.8

52.9 ± 10.4

0.89

Gender(Male/Female) (n)

51/77

51/77

1.00

BMI (kg/m2)

23.7 ± 0.3

24.1 ± 0.3

0.27

BSA (m2)

1.66 ± 0.01

1.69 ± 0.01

0.32

NYHA classification (I/II/III/IV)(n)

4/78/42/4

6/62/52/8

0.201

Preoperative

   

Mitral valve area(cm2)

1.2 ± 0.2

1.2 ± 0.3

0.97

Left atrial appendage thrombi(n)

14

20

0.269

LAD (mm)

50.5 ± 0.8

51.3 ± 0.7

0.44

LVD(mm)

52.4 ± 0.7

53.0 ± 0.7

0.50

Pulmonary Pressure

35.6 ± 0.7

35.5 ± 0.6

0.89

Operative and perioperative variables

   

Concomitant procedure

   

RFCA(n)

46

89

< 0.01

Aortic Valve surgery(n)

17

27

0.10

TVP(n)

89

112

< 0.01

right infra-axillary vertical thoracotomy(n)

27

11

< 0.01

CPB time(min)

105 ± 15

125 ± 28

< 0.01

X-clamp time(min)

70 ± 16

85 ± 29

< 0.01

Mechanical Ventilation(h)

7.2 ± 2.7

9.3 ± 3.7

< 0.01

Post-operative discharge(d)

7.6 ± 2.1

8.9 ± 2.6

0.03

End diastolic peak flow velocity(m/s)

1.2 ± 0.3

1.6 ± 0.4

< 0.01

Transvalvular pressure gradients (mmHg)

2.7 ± 1.1

3.8 ± 1.2

0.01